{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:16:37Z","timestamp":1787678197486,"version":"build-2784847793"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the College Students' Innovation and Entrepreneurship Training Program Project of Zunyi Medical University","award":["S202310661178"],"award-info":[{"award-number":["S202310661178"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060503"],"award-info":[{"award-number":["82060503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Project of the Guizhou Provincial Department of Science and Technology","award":["QKH-JC-ZK-2022-622"],"award-info":[{"award-number":["QKH-JC-ZK-2022-622"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02641-w","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T09:14:48Z","timestamp":1748164488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reciprocal regulation between m6 A modifications and non-coding RNAs: emerging roles in cancer therapeutic resistance"],"prefix":"10.1007","volume":"16","author":[{"given":"Dan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"1","key":"2641_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA A Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA A Cancer J Clin."},{"issue":"6","key":"2641_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1200\/JCO.21.01881","volume":"40","author":"J Zugazagoitia","year":"2022","unstructured":"Zugazagoitia J, Paz-Ares L. Extensive-stage small-cell lung cancer: first-line and second-line treatment options. J Clin Oncol. 2022;40(6):671\u201380.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2641_CR3","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12(1):1786.","journal-title":"Nat Commun"},{"issue":"7766","key":"2641_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571(7766):489\u201399.","journal-title":"Nature"},{"issue":"1","key":"2641_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"WW Liu","year":"2024","unstructured":"Liu WW, Zheng SQ, Li T, Fei YF, Wang C, Zhang S, et al. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther. 2024;9(1):70.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"2641_CR6","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1974;71(10):3971\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2641_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.670711","volume":"9","author":"J Luo","year":"2021","unstructured":"Luo J, Xu T, Sun K. N6-methyladenosine RNA modification in inflammation: roles, mechanisms, and applications. Front Cell Dev Biol. 2021;9: 670711.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"2641_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149(7):1635\u201346.","journal-title":"Cell"},{"issue":"1","key":"2641_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang H, Yu B, Tao D, Xu X, Xu Y, Wang J, et al. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22(1):91.","journal-title":"Mol Cancer"},{"issue":"3","key":"2641_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s12276-023-00944-y","volume":"55","author":"Z Liu","year":"2023","unstructured":"Liu Z, Gao L, Cheng L, Lv G, Sun B, Wang G, et al. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. Exp Mol Med. 2023;55(3):487\u2013501.","journal-title":"Exp Mol Med"},{"key":"2641_CR11","doi-asserted-by":"publisher","first-page":"1480572","DOI":"10.3389\/fimmu.2024.1480572","volume":"15","author":"Y Gong","year":"2024","unstructured":"Gong Y, Gong D, Liu S, Gong X, Xiong J, Zhang J, et al. Deciphering the role of NcRNAs in pancreatic cancer immune evasion and drug resistance: a new perspective for targeted therapy. Front Immunol. 2024;15:1480572.","journal-title":"Front Immunol"},{"key":"2641_CR12","doi-asserted-by":"crossref","unstructured":"Valenzuela G, Contreras HR, Marcelain K, Burotto M, Gonz\u00e1lez-Montero J. Understanding microRNA-mediated chemoresistance in colorectal cancer treatment. Int J Mol Sci. 2025;26(3):1168.","DOI":"10.3390\/ijms26031168"},{"key":"2641_CR13","doi-asserted-by":"crossref","unstructured":"Elahi MA, Tariq A, Malik A, Zhra M. Role of hypoxia-associated long noncoding RNAs in cancer chemo-therapy resistance. Int J Mol Sci. 2025;26(3):936.","DOI":"10.3390\/ijms26030936"},{"issue":"1","key":"2641_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","volume":"13","author":"L Meng","year":"2022","unstructured":"Meng L, Lin H, Huang X, Weng J, Peng F, Wu S. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell Death Dis. 2022;13(1):38.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41467-022-28990-6","volume":"13","author":"G Li","year":"2022","unstructured":"Li G, Ma L, He S, Luo R, Wang B, Zhang W, et al. WTAP-mediated m(6)A modification of lncRNA NORAD promotes intervertebral disc degeneration. Nat Commun. 2022;13(1):1469.","journal-title":"Nat Commun"},{"issue":"1","key":"2641_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121.","journal-title":"J Hematol Oncol"},{"key":"2641_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117331","volume":"179","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Jian N, Jiang C, Wang J. m(6)A modification in non-coding RNAs: mechanisms and potential therapeutic implications in fibrosis. Biomed Pharmacothera. 2024;179: 117331.","journal-title":"Biomed Pharmacothera."},{"issue":"2","key":"2641_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306\u201317.","journal-title":"Mol Cell"},{"issue":"2","key":"2641_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389.","journal-title":"Cell Res"},{"issue":"15","key":"2641_CR20","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1093\/nar\/gkz619","volume":"47","author":"N van Tran","year":"2019","unstructured":"van Tran N, Ernst FGM, Hawley BR, Zorbas C, Ulryck N, Hackert P, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res. 2019;47(15):7719\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2641_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","volume":"24","author":"R Su","year":"2022","unstructured":"Su R, Dong L, Li Y, Gao M, He PC, Liu W, et al. METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis. Nat Cell Biol. 2022;24(2):205\u201316.","journal-title":"Nat Cell Biol"},{"issue":"7620","key":"2641_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369\u201373.","journal-title":"Nature"},{"issue":"1","key":"2641_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cas.15177","volume":"113","author":"S Liu","year":"2022","unstructured":"Liu S, Jiang Z, Xiao P, Li X, Chen Y, Tang H, et al. Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p\/IGF1R axis in lung adenocarcinoma cells. Cancer Sci. 2022;113(1):79\u201390.","journal-title":"Cancer Sci"},{"key":"2641_CR24","doi-asserted-by":"crossref","unstructured":"Zhang X, Li Mj, Xia L, Zhang H. The biological function of m6A methyltransferase KIAA1429 and its role in human disease. PeerJ. 2022;10:e14334.","DOI":"10.7717\/peerj.14334"},{"key":"2641_CR25","doi-asserted-by":"crossref","unstructured":"Azzam SK, Alsafar H, Sajini AA. FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms. Int J Mol Sci. 2022;23(7):3800.","DOI":"10.3390\/ijms23073800"},{"key":"2641_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12935-020-01450-1","volume":"20","author":"J Wang","year":"2020","unstructured":"Wang J, Wang J, Gu Q, Ma Y, Yang Y, Zhu J, et al. The biological function of m6A demethylase ALKBH5 and its role in human disease. Cancer Cell Int. 2020;20:347.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2641_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41420-022-00947-0","volume":"8","author":"J Liao","year":"2022","unstructured":"Liao J, Wei Y, Liang J, Wen J, Chen X, Zhang B, et al. Insight into the structure, physiological function, and role in cancer of m6A readers\u2014YTH domain-containing proteins. Cell Death Discov. 2022;8(1):137.","journal-title":"Cell Death Discov"},{"key":"2641_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.607224","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Qiu D, Yu A, Hu J, Deng H, Li H, et al. YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy. Front Oncol. 2021;11: 607224.","journal-title":"Front Oncol"},{"issue":"6","key":"2641_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","volume":"38","author":"G Chang","year":"2020","unstructured":"Chang G, Shi L, Ye Y, Shi H, Zeng L, Tiwary S, et al. YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell. 2020;38(6):857-71.e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"2641_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12935-021-01807-0","volume":"21","author":"JY Wang","year":"2021","unstructured":"Wang JY, Lu AQ. The biological function of m6A reader YTHDF2 and its role in human disease. Cancer Cell Int. 2021;21(1):109.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"2641_CR31","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41556-023-01141-9","volume":"25","author":"A Navickas","year":"2023","unstructured":"Navickas A, Asgharian H, Winkler J, Fish L, Garcia K, Markett D, et al. An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus. Nat Cell Biol. 2023;25(6):892\u2013903.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2641_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molcel.2019.07.005","volume":"76","author":"KI Zhou","year":"2019","unstructured":"Zhou KI, Shi H, Lyu R, Wylder AC, Matuszek Z, Pan JN, et al. Regulation of Co-transcriptional Pre-mRNA splicing by m(6)A through the low-complexity protein hnRNPG. Mol Cell. 2019;76(1):70-81 e9.","journal-title":"Mol Cell"},{"issue":"24","key":"2641_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307639","volume":"11","author":"T Jin","year":"2024","unstructured":"Jin T, Yang L, Chang C, Luo H, Wang R, Gan Y, et al. HnRNPA2B1 ISGylation regulates m6A-tagged mRNA selective export via ALYREF\/NXF1 complex to foster breast cancer development. Adv Sci (Weinh). 2024;11(24): e2307639.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"2641_CR34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41419-021-04038-3","volume":"12","author":"Y Ying","year":"2021","unstructured":"Ying Y, Ma X, Fang J, Chen S, Wang W, Li J, et al. EGR2-mediated regulation of m(6)A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization. Cell Death Dis. 2021;12(8):750.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2021.09.014","volume":"29","author":"R Yin","year":"2022","unstructured":"Yin R, Chang J, Li Y, Gao Z, Qiu Q, Wang Q, et al. Differential m(6)A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function. Cell Stem Cell. 2022;29(1):149-59 e7.","journal-title":"Cell Stem Cell"},{"key":"2641_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00552-7","author":"B Qian","year":"2021","unstructured":"Qian B, Wang P, Zhang D, Wu L. m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2. Cell Death Discovery. 2021;7(1):157.","journal-title":"Cell Death Discov."},{"issue":"5","key":"2641_CR37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.molcel.2020.10.028","volume":"80","author":"GM Rice","year":"2020","unstructured":"Rice GM, Shivashankar V, Ma EJ, Baryza JL, Nutiu R. Functional Atlas of Primary miRNA Maturation by the Microprocessor. Mol Cell. 2020;80(5):892-902 e4.","journal-title":"Mol Cell"},{"issue":"17","key":"2641_CR38","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/1873-3468.13196","volume":"592","author":"SK Pong","year":"2018","unstructured":"Pong SK, Gullerova M. Noncanonical functions of microRNA pathway enzymes\u2014Drosha, DGCR8, Dicer and Ago proteins. FEBS Lett. 2018;592(17):2973\u201386.","journal-title":"FEBS Lett"},{"issue":"2","key":"2641_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"7544","key":"2641_CR40","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarcon","year":"2015","unstructured":"Alarcon CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature. 2015;519(7544):482\u20135.","journal-title":"Nature"},{"issue":"1","key":"2641_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lin Y, Shu Y, He J, Gao W. Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer. Mol Cancer. 2020;19(1):94.","journal-title":"Mol Cancer"},{"key":"2641_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217058","volume":"597","author":"S Wu","year":"2024","unstructured":"Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, et al. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK\/T cell lymphoma growth. Cancer Lett. 2024;597: 217058.","journal-title":"Cancer Lett"},{"issue":"5","key":"2641_CR43","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/biolre\/ioab152","volume":"105","author":"X Li","year":"2021","unstructured":"Li X, Xiong W, Long X, Dai X, Peng Y, Xu Y, et al. Inhibition of METTL3\/m6A\/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosisdagger. Biol Reprod. 2021;105(5):1221\u201333.","journal-title":"Biol Reprod"},{"issue":"1","key":"2641_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113712","volume":"430","author":"L Liang","year":"2023","unstructured":"Liang L, Liu S, Wu Q, Chen R, Jiang S, Yang Z. m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3\/ miRNA-193a\/BCL2L2 pathway. Exp Cell Res. 2023;430(1): 113712.","journal-title":"Exp Cell Res"},{"issue":"8","key":"2641_CR45","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1007\/s00432-022-04429-9","volume":"149","author":"L Huang","year":"2023","unstructured":"Huang L, Liang D, Zhang Y, Chen X, Chen J, Wen C, et al. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b. J Cancer Res Clin Oncol. 2023;149(8):5095\u2013108.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"23","key":"2641_CR46","doi-asserted-by":"publisher","first-page":"14013","DOI":"10.1111\/jcmm.16012","volume":"24","author":"L Xiao","year":"2020","unstructured":"Xiao L, Zhao Q, Hu B, Wang J, Liu C, Xu H. METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p. J Cell Mol Med. 2020;24(23):14013\u201325.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2641_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s11658-022-00349-1","volume":"27","author":"R Zhang","year":"2022","unstructured":"Zhang R, Qu Y, Ji Z, Hao C, Su Y, Yao Y, et al. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221\/222 maturation in an m6A-dependent manner. Cell Mol Biol Lett. 2022;27(1):55.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"2641_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40035-023-00386-6","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang X, Xie J, Tan L, Lu Y, Shen N, Li J, et al. N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer\u2019s disease. Transl Neurodegener. 2023;12(1):53.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"2641_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13019-024-02711-0","volume":"19","author":"C Zhao","year":"2024","unstructured":"Zhao C, Li J. METTL14-mediated N6-methyladenosine modification induces the ferroptosis of hypoxia\/reoxygenation-induced cardiomyocytes. J Cardiothorac Surg. 2024;19(1):265.","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"2641_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41420-021-00724-5","volume":"7","author":"G Zhou","year":"2021","unstructured":"Zhou G, Yan K, Liu J, Gao L, Jiang X, Fan Y. FTO promotes tumour proliferation in bladder cancer via the FTO\/miR-576\/CDK6 axis in an m6A-dependent manner. Cell death discovery. 2021;7(1):329.","journal-title":"Cell death discovery"},{"issue":"1","key":"2641_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3724\/abbs.2023267","volume":"56","author":"J Ni","year":"2024","unstructured":"Ni J, Lu X, Gao X, Jin C, Mao J. Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m (6)A-dependent miR-17-5p maturation-induced ZBTB4 depletion. Acta Biochim Biophys Sin (Shanghai). 2024;56(1):114\u201328.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"2","key":"2641_CR52","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s13577-020-00458-z","volume":"34","author":"J Xue","year":"2021","unstructured":"Xue J, Xiao P, Yu X, Zhang X. A positive feedback loop between AlkB homolog 5 and miR-193a-3p promotes growth and metastasis in esophageal squamous cell carcinoma. Hum Cell. 2021;34(2):502\u201314.","journal-title":"Hum Cell"},{"issue":"1","key":"2641_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.gendis.2023.01.016","volume":"11","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhou K, Han L, Small A, Xue J, Huang H, et al. RNA m(6)A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression. Genes Dis. 2024;11(1):382\u201396.","journal-title":"Genes Dis"},{"issue":"11","key":"2641_CR54","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/s41418-021-00804-0","volume":"28","author":"Y Hou","year":"2021","unstructured":"Hou Y, Zhang Q, Pang W, Hou L, Liang Y, Han X, et al. YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect. Cell Death Differ. 2021;28(11):3105\u201324.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2641_CR55","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/2211-5463.13409","volume":"12","author":"MGP dos Santos","year":"2022","unstructured":"dos Santos MGP, Gatti da Silva GH, Nagasse HY, Fuziwara CS, Kimura ET, Coltri PP. hnRNP A1 and hnRNP C associate with miR-17 and miR-18 in thyroid cancer cells. FEBS Open Bio. 2022;12(6):1253\u201364.","journal-title":"FEBS Open Bio"},{"issue":"7","key":"2641_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nsmb1250","volume":"14","author":"S Guil","year":"2007","unstructured":"Guil S, C\u00e1ceres JF. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol. 2007;14(7):591\u20136.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"2641_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41419-020-03315-x","volume":"12","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Yan G, He M, Lei H, Li L, Wang Y, et al. ALKBH5 suppresses tumor progression via an m(6)A-dependent epigenetic silencing of pre-miR-181b-1\/YAP signaling axis in osteosarcoma. Cell Death Dis. 2021;12(1):60.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2641_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2023.110704","volume":"115","author":"X Ling","year":"2023","unstructured":"Ling X, Wang R, Lin L, Wu Y, Cheng W. N6-methyladenosine-modified microRNA-675 advances the development of gastrointestinal stromal tumors via inhibiting myosin phosphatase targeting protein 1. Genomics. 2023;115(5): 110704.","journal-title":"Genomics"},{"issue":"2","key":"2641_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41419-023-05670-x","volume":"14","author":"K Sun","year":"2023","unstructured":"Sun K, Chen L, Li Y, Huang B, Yan Q, Wu C, et al. METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer. Cell Death Dis. 2023;14(2):148.","journal-title":"Cell Death Dis"},{"issue":"18","key":"2641_CR60","doi-asserted-by":"publisher","first-page":"22332","DOI":"10.18632\/aging.203541","volume":"13","author":"H Ma","year":"2021","unstructured":"Ma H, Zhang F, Zhong Q, Hou J. METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d. Aging. 2021;13(18):22332\u201344.","journal-title":"Aging"},{"key":"2641_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111068","volume":"117","author":"Y Gong","year":"2024","unstructured":"Gong Y, Luo G, Zhang S, Chen Y, Hu Y. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3\/KRAS axis. Cell Signal. 2024;117: 111068.","journal-title":"Cell Signal"},{"issue":"1","key":"2641_CR62","doi-asserted-by":"publisher","first-page":"13587","DOI":"10.1038\/s41598-023-39506-7","volume":"13","author":"X Su","year":"2023","unstructured":"Su X, Lai T, Tao Y, Zhang Y, Zhao C, Zhou J, et al. miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis. Sci Rep. 2023;13(1):13587.","journal-title":"Sci Rep"},{"issue":"3","key":"2641_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12768","volume":"53","author":"X Cui","year":"2020","unstructured":"Cui X, Wang Z, Li J, Zhu J, Ren Z, Zhang D, et al. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt\/beta-catenin signalling pathway. Cell Prolif. 2020;53(3): e12768.","journal-title":"Cell Prolif"},{"issue":"1","key":"2641_CR64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10020-021-00355-7","volume":"27","author":"X Yuan","year":"2021","unstructured":"Yuan X, Li T, Shi L, Miao J, Guo Y, Chen Y. Human umbilical cord mesenchymal stem cells deliver exogenous miR-26a-5p via exosomes to inhibit nucleus pulposus cell pyroptosis through METTL14\/NLRP3. Mol Med. 2021;27(1):91.","journal-title":"Mol Med"},{"issue":"5","key":"2641_CR65","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.18632\/aging.203939","volume":"14","author":"S Wu","year":"2022","unstructured":"Wu S, Liu S, Cao Y, Chao G, Wang P, Pan H. Downregulation of ZC3H13 by miR-362-3p\/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma. Aging. 2022;14(5):2304\u201319.","journal-title":"Aging"},{"issue":"1","key":"2641_CR66","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13046-020-01731-7","volume":"39","author":"C Yue","year":"2020","unstructured":"Yue C, Chen J, Li Z, Li L, Chen J, Guo Y. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKalpha2-FTO-m6A\/MYC axis. J Exp Clin Cancer Res. 2020;39(1):240.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2641_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/cjop.CJOP-D-22-00071","volume":"66","author":"X Li","year":"2023","unstructured":"Li X, Liu B, Wang S, Li J, Ge X. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m(6)A modification of protein arginine methyltransferase 6. Chin J Physiol. 2023;66(1):43\u201351.","journal-title":"Chin J Physiol"},{"issue":"10","key":"2641_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.602","volume":"11","author":"H Li","year":"2021","unstructured":"Li H, Zhang N, Jiao X, Wang C, Sun W, He Y, et al. Downregulation of microRNA-6125 promotes colorectal cancer growth through YTHDF2-dependent recognition of N6-methyladenosine-modified GSK3beta. Clin Transl Med. 2021;11(10): e602.","journal-title":"Clin Transl Med"},{"issue":"9","key":"2641_CR69","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1074\/jbc.M116.749689","volume":"292","author":"Z Yang","year":"2017","unstructured":"Yang Z, Li J, Feng G, Gao S, Wang Y, Zhang S, et al. MicroRNA-145 modulates N(6)-methyladenosine levels by targeting the 3\u2019-untranslated mRNA region of the N(6)-methyladenosine binding YTH domain family 2 protein. J Biol Chem. 2017;292(9):3614\u201323.","journal-title":"J Biol Chem"},{"issue":"1","key":"2641_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13048-020-00717-5","volume":"13","author":"J Li","year":"2020","unstructured":"Li J, Wu L, Pei M, Zhang Y. YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells. J Ovarian Res. 2020;13(1):111.","journal-title":"J Ovarian Res"},{"issue":"13","key":"2641_CR71","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1111\/jcmm.15382","volume":"24","author":"C Xu","year":"2020","unstructured":"Xu C, Yuan B, He T, Ding B, Li S. Prognostic values of YTHDF1 regulated negatively by mir-3436 in Glioma. J Cell Mol Med. 2020;24(13):7538\u201349.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2641_CR72","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-022-04711-1","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao X, Li W, Li L, Li M, Zhao Y, Fang D, et al. YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell Death Dis. 2022;13(3):258.","journal-title":"Cell Death Dis"},{"key":"2641_CR73","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202009045","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.","journal-title":"J Cell Biol"},{"issue":"12","key":"2641_CR74","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252\u201366.","journal-title":"Mol Cell"},{"issue":"20","key":"2641_CR75","doi-asserted-by":"publisher","first-page":"11619","DOI":"10.1093\/nar\/gkac1027","volume":"50","author":"L Chen","year":"2022","unstructured":"Chen L, Zhang C, Ma W, Huang J, Zhao Y, Liu H. METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability. Nucleic Acids Res. 2022;50(20):11619\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2641_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113149","volume":"416","author":"J Liu","year":"2022","unstructured":"Liu J, Yuan JF, Wang YZ. METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1\/c-Myc axis. Exp Cell Res. 2022;416(1): 113149.","journal-title":"Exp Cell Res"},{"issue":"1","key":"2641_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00018-025-05594-z","volume":"82","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Han R, Wang M, Wang S, Zhou J, Wang J, et al. M(6)A-mediated lncRNA SCIRT stability promotes NSCLC progression through binding to SFPQ and activating the PI3K\/Akt pathway. Cell Mol Life Sci CMLS. 2025;82(1):63.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2641_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216746","volume":"588","author":"M Chang","year":"2024","unstructured":"Chang M, Cui X, Sun Q, Wang Y, Liu J, Sun Z, et al. Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21. Cancer Lett. 2024;588: 216746.","journal-title":"Cancer Lett"},{"issue":"6","key":"2641_CR79","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41418-021-00905-w","volume":"29","author":"ZX Li","year":"2022","unstructured":"Li ZX, Zheng ZQ, Yang PY, Lin L, Zhou GQ, Lv JW, et al. WTAP-mediated m(6)A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis. Cell Death Differ. 2022;29(6):1137\u201351.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2641_CR80","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-024-02965-5","volume":"43","author":"K Chen","year":"2024","unstructured":"Chen K, Zhang J, Meng L, Kong L, Lu M, Wang Z, et al. The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis. J Exp Clin Cancer Res. 2024;43(1):44.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"2641_CR81","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1111\/cas.15581","volume":"113","author":"D Fang","year":"2022","unstructured":"Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, et al. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 2022;113(12):4135\u201350.","journal-title":"Cancer Sci"},{"issue":"2","key":"2641_CR82","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/jcmm.17091","volume":"26","author":"Y Li","year":"2022","unstructured":"Li Y, Yan B, Wang X, Li Q, Kan X, Wang J, et al. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9. J Cell Mol Med. 2022;26(2):385\u201398.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2641_CR83","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41419-022-05386-4","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Liu Y, Wang W, Liu F, Wang W, Su C, et al. ALKBH5-mediated m(6)A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis. Cell Death Dis. 2022;13(11):926.","journal-title":"Cell Death Dis"},{"key":"2641_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111483","volume":"128","author":"N Yang","year":"2024","unstructured":"Yang N, Yan N, Bai Z, Du S, Zhang J, Zhang L, et al. FTO attenuates LPS-induced acute kidney injury by inhibiting autophagy via regulating SNHG14\/miR-373-3p\/ATG7 axis. Int Immunopharmacol. 2024;128: 111483.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"2641_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22595","volume":"9","author":"R Zhang","year":"2023","unstructured":"Zhang R, Yang R, Huang Z, Xu X, Lv S, Guan X, et al. METTL3\/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression. Heliyon. 2023;9(12): e22595.","journal-title":"Heliyon"},{"key":"2641_CR86","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5641","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhu Y, Zhang Y, Liu Z, Zhao X. YTHDF1 promotes the viability and self\u2011renewal of glioma stem cells by enhancing LINC00900 stability. Int J Oncol. 2024;64(5):53.","journal-title":"Int J Oncol"},{"key":"2641_CR87","doi-asserted-by":"publisher","first-page":"963689720964382","DOI":"10.1177\/0963689720964382","volume":"29","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang D, Wu D, Zhang D, Sun M. Long noncoding RNA KCNMB2-AS1 stabilized by N(6)-methyladenosine modification promotes cervical cancer growth through acting as a competing endogenous RNA. Cell Transplant. 2020;29:963689720964382.","journal-title":"Cell Transplant"},{"issue":"3","key":"2641_CR88","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"key":"2641_CR89","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5529","author":"W Liu","year":"2023","unstructured":"Liu W, Zhang Z, Luo X, Qian K, Huang B, Liang J, et al. m(6)A\u2011mediated LINC02038 inhibits colorectal cancer progression via regulation of the FAM172A\/PI3K\/AKT pathway via competitive binding with miR\u2011552\u20115p. Int J Oncol. 2023;63(1):81.","journal-title":"Int J Oncol"},{"issue":"7","key":"2641_CR90","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.7150\/ijbs.70630","volume":"18","author":"K Shi","year":"2022","unstructured":"Shi K, Yang S, Chen C, Shao B, Guo Y, Wu X, et al. RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p\/PTEN axis. Int J Biol Sci. 2022;18(7):3048\u201365.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"2641_CR91","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3892\/ijo.2020.5142","volume":"57","author":"H Song","year":"2020","unstructured":"Song H, Li H, Ding X, Li M, Shen H, Li Y, et al. Long non-coding RNA FEZF1-AS1 facilitates non-small cell lung cancer progression via the ITGA11\/miR-516b-5p axis. Int J Oncol. 2020;57(6):1333\u201347.","journal-title":"Int J Oncol"},{"issue":"1","key":"2641_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","volume":"13","author":"X Zuo","year":"2020","unstructured":"Zuo X, Chen Z, Gao W, Zhang Y, Wang J, Wang J, et al. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol. 2020;13(1):5.","journal-title":"J Hematol Oncol"},{"key":"2641_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629947","volume":"11","author":"X Meng","year":"2021","unstructured":"Meng X, Deng Y, He S, Niu L, Zhu H. m(6)A-mediated upregulation of LINC00857 promotes pancreatic cancer tumorigenesis by regulating the miR-150-5p\/E2F3 axis. Front Oncol. 2021;11: 629947.","journal-title":"Front Oncol"},{"key":"2641_CR94","doi-asserted-by":"publisher","first-page":"963689723118830","DOI":"10.1177\/09636897231188300","volume":"32","author":"S Chu","year":"2023","unstructured":"Chu S, Li Y, Wu B, Rong G, Hou Q, Zhou Q, et al. METTL3 promotes the growth and invasion of melanoma cells by regulating the lncRNA SNHG3\/miR-330-5p axis. Cell Transplant. 2023;32:9636897231188300.","journal-title":"Cell Transplant"},{"issue":"5","key":"2641_CR95","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.7150\/ijbs.86658","volume":"20","author":"Z Zeng","year":"2024","unstructured":"Zeng Z, Wang J, Xu F, Hu P, Hu Y, Zhuo W, et al. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma. Int J Biol Sci. 2024;20(5):1744\u201362.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2641_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2023.110593","volume":"115","author":"S Ke","year":"2023","unstructured":"Ke S, Wang J, Lu J, Fang M, Li R. Long intergenic non-protein coding RNA 00858 participates in the occurrence and development of esophageal squamous cell carcinoma through the activation of the FTO-m6A-MYC axis by recruiting ZNF184. Genomics. 2023;115(3): 110593.","journal-title":"Genomics"},{"issue":"6","key":"2641_CR97","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/cas.15366","volume":"113","author":"X Chen","year":"2022","unstructured":"Chen X, Liu Y, Sun D, Sun R, Wang X, Li M, et al. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma. Cancer Sci. 2022;113(6):2071\u201384.","journal-title":"Cancer Sci"},{"issue":"1","key":"2641_CR98","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-019-1105-0","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen YX, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18(1):174.","journal-title":"Mol Cancer"},{"key":"2641_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2020.09.023","volume":"23","author":"M Ye","year":"2021","unstructured":"Ye M, Dong S, Hou H, Zhang T, Shen M. Oncogenic role of long noncoding RNAMALAT1 in thyroid cancer progression through regulation of the miR-204\/IGF2BP2\/m6A-MYC signaling. Mol Ther Nucleic Acids. 2021;23:1\u201312.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"38","key":"2641_CR100","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42(38):2783\u2013800.","journal-title":"Oncogene"},{"issue":"9","key":"2641_CR101","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1101\/gr.202895.115","volume":"26","author":"X-O Zhang","year":"2016","unstructured":"Zhang X-O, Dong R, Zhang Y, Zhang J-L, Luo Z, Zhang J, et al. Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res. 2016;26(9):1277\u201387.","journal-title":"Genome Res"},{"issue":"11","key":"2641_CR102","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675\u201391.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2641_CR103","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"W-Y Zhou","year":"2020","unstructured":"Zhou W-Y, Cai Z-R, Liu J, Wang D-S, Ju H-Q, Xu R-H. Circular RNA: metabolism, functions and interactions with proteins. Molecular Cancer. 2020;19(1):172.","journal-title":"Mol Cancer"},{"key":"2641_CR104","doi-asserted-by":"crossref","unstructured":"Diallo LH, Tatin F, David F, Godet AC, Zamora A, Prats AC, et al. How are circRNAs translated by non-canonical initiation mechanisms? Biochimie. 2019;164:45-52.","DOI":"10.1016\/j.biochi.2019.06.015"},{"issue":"9","key":"2641_CR105","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.7150\/thno.51342","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen C, Yuan W, Zhou Q, Shao B, Guo Y, Wang W, et al. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization. Theranostics. 2021;11(9):4298\u2013315.","journal-title":"Theranostics"},{"issue":"2","key":"2641_CR106","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-023-05570-0","volume":"14","author":"H Guan","year":"2023","unstructured":"Guan H, Tian K, Luo W, Li M. m(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A\/PD-L1 manner. Cell Death Dis. 2023;14(2):120.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR107","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20(1):105.","journal-title":"Mol Cancer"},{"issue":"12","key":"2641_CR108","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/1541-7786.MCR-22-0271","volume":"21","author":"Z Kong","year":"2023","unstructured":"Kong Z, Lu Y, Yang Y, Chang K, Lin Y, Huang Y, et al. m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1\/HuR. Mol Cancer Res. 2023;21(12):1342\u201355.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"2641_CR109","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/iub.2438","volume":"73","author":"X Rao","year":"2021","unstructured":"Rao X, Lai L, Li X, Wang L, Li A, Yang Q. N(6)-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305. IUBMB Life. 2021;73(2):408\u201317.","journal-title":"IUBMB Life"},{"issue":"10","key":"2641_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108022","volume":"26","author":"Y Wei","year":"2023","unstructured":"Wei Y, Fu J, Zhang H, Ling Y, Tang X, Liu S, et al. N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes. iScience. 2023;26(10): 108022.","journal-title":"iScience."},{"issue":"34","key":"2641_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304895","volume":"10","author":"Z Wu","year":"2023","unstructured":"Wu Z, Zuo X, Zhang W, Li Y, Gui R, Leng J, et al. m6A-Modified circTET2 interacting with HNRNPC regulates fatty acid oxidation to promote the proliferation of chronic lymphocytic leukemia. Adv Sci (Weinh). 2023;10(34): e2304895.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"2641_CR112","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molmed.2022.03.003","volume":"28","author":"SY Wen","year":"2022","unstructured":"Wen SY, Qadir J, Yang BB. Circular RNA translation: novel protein isoforms and clinical significance. Trends Mol Med. 2022;28(5):405\u201320.","journal-title":"Trends Mol Med"},{"key":"2641_CR113","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biochi.2019.06.015","volume":"164","author":"LH Diallo","year":"2019","unstructured":"Diallo LH, Tatin F, David F, Godet A-C, Zamora A, Prats A-C, et al. How are circRNAs translated by non-canonical initiation mechanisms? Biochimie. 2019;164:45\u201352.","journal-title":"Biochimie"},{"key":"2641_CR114","doi-asserted-by":"crossref","unstructured":"Zeng K, Peng J, Xing Y, Zhang L, Zeng P, Li W, et al. A positive feedback circuit driven by m(6)A-modified circular RNA facilitates colorectal cancer liver metastasis. Molecular cancer. 2023;22(1):202.","DOI":"10.1186\/s12943-023-01848-1"},{"issue":"6","key":"2641_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107641","volume":"31","author":"G Di Timoteo","year":"2020","unstructured":"Di Timoteo G, Dattilo D, Centron-Broco A, Colantoni A, Guarnacci M, Rossi F, et al. Modulation of circRNA metabolism by m(6)A modification. Cell Rep. 2020;31(6): 107641.","journal-title":"Cell Rep"},{"issue":"4","key":"2641_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1658","volume":"14","author":"H Li","year":"2024","unstructured":"Li H, Tang Y, Ruan X, Zhang J, Liu H, Yu S, et al. N6-methyladenosine-modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis. Clin Transl Med. 2024;14(4): e1658.","journal-title":"Clin Transl Med"},{"issue":"8","key":"2641_CR117","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/mc.23744","volume":"63","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wu Y, Shi X, Ding H, Zhou Y, Chen H, et al. M6A-mediated hsa_circ_0061179 inhibits DNA damage in ovarian cancer cells via miR-143-3p\/TIMELESS. Mol Carcinog. 2024;63(8):1542\u201358.","journal-title":"Mol Carcinog"},{"key":"2641_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.762588","volume":"9","author":"A Wu","year":"2021","unstructured":"Wu A, Hu Y, Xu Y, Xu J, Wang X, Cai A, et al. Methyltransferase-like 3-mediated m6A methylation of Hsa_circ_0058493 accelerates hepatocellular carcinoma progression by binding to YTH domain-containing protein 1. Front Cell Dev Biol. 2021;9: 762588.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2641_CR119","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-024-03113-9","volume":"43","author":"G Shu","year":"2024","unstructured":"Shu G, Zhao Z, Zhao T, Deng C, Zhu J, Han Y, et al. N(6)-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor. J Exp Clin Cancer Res. 2024;43(1):191.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"2641_CR120","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.7150\/ijbs.60131","volume":"17","author":"M Tang","year":"2021","unstructured":"Tang M, Lv Y. The role of N6-methyladenosine modified circular RNA in pathophysiological processes. Int J Biol Sci. 2021;17(9):2262\u201377.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2641_CR121","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.molcel.2019.02.034","volume":"74","author":"OH Park","year":"2019","unstructured":"Park OH, Ha H, Lee Y, Boo SH, Kwon DH, Song HK, et al. Endoribonucleolytic cleavage of m6A-containing RNAs by RNase P\/MRP complex. Mol Cell. 2019;74(3):494-507.e8.","journal-title":"Mol Cell"},{"issue":"1","key":"2641_CR122","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13297","volume":"56","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang Y, Lin Y, Wei B, Hu X, Xu L, et al. N(6) -methyladenosine-modified circRNA RERE modulates osteoarthritis by regulating beta-catenin ubiquitination and degradation. Cell Prolif. 2023;56(1): e13297.","journal-title":"Cell Prolif"},{"key":"2641_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115456","volume":"210","author":"D Wang","year":"2023","unstructured":"Wang D, Guan H, Xia Y. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1. Biochem Pharmacol. 2023;210: 115456.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2641_CR124","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43556-024-00172-4","volume":"5","author":"X Wu","year":"2024","unstructured":"Wu X, Fang Y, Gu Y, Shen H, Xu Y, Xu T, et al. Fat mass and obesity-associated protein (FTO) mediated m(6)A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay. Mol Biomed. 2024;5(1):11.","journal-title":"Mol Biomed"},{"issue":"1","key":"2641_CR125","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-022-01560-6","volume":"21","author":"C Lin","year":"2022","unstructured":"Lin C, Ma M, Zhang Y, Li L, Long F, Xie C, et al. The N(6)-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p\/PGF signalling pathway. Mol Cancer. 2022;21(1):80.","journal-title":"Mol Cancer"},{"key":"2641_CR126","doi-asserted-by":"crossref","unstructured":"Lin Y-h, Zhang B-y, Chen Z-c. circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13\/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells. J Biosci. 2022;47(3):52.","DOI":"10.1007\/s12038-022-00298-z"},{"issue":"1","key":"2641_CR127","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-023-00495-4","volume":"11","author":"X Yang","year":"2023","unstructured":"Yang X, Han F, Hu X, Li G, Wu H, Can C, et al. EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p\/RNF113A pathway. Biomark Res. 2023;11(1):59.","journal-title":"Biomark Res"},{"issue":"1","key":"2641_CR128","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12943-025-02239-4","volume":"24","author":"X Xu","year":"2025","unstructured":"Xu X, Peng Q, Ren Z, Han Y, Jiang X, Wu Z, et al. CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance. Mol Cancer. 2025;24(1):36.","journal-title":"Mol Cancer"},{"issue":"2","key":"2641_CR129","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41419-021-03486-1","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhu H, Hu J. CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129. Cell Death Dis. 2021;12(2):219.","journal-title":"Cell Death Dis"},{"key":"2641_CR130","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ncrna.2024.08.001","volume":"10","author":"Y Gu","year":"2025","unstructured":"Gu Y, Sheng L, Wei X, Chen Y, Lin Y, Li Z, et al. Upregulation of circGDI2 inhibits tumorigenesis by stabilizing the expression of RNA m6A demethylase FTO in oral squamous cell carcinoma. Non-Coding RNA Res. 2025;10:140\u201352.","journal-title":"Non-Coding RNA Res"},{"key":"2641_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107451","volume":"141","author":"K Zhu","year":"2024","unstructured":"Zhu K, Gou F, Zhao Z, Xu K, Song J, Jiang H, et al. Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5. Leuk Res. 2024;141: 107451.","journal-title":"Leuk Res"},{"key":"2641_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.652129","volume":"12","author":"P Morais","year":"2021","unstructured":"Morais P, Adachi H, Yu YT. Spliceosomal snRNA epitranscriptomics. Front Genet. 2021;12: 652129.","journal-title":"Front Genet"},{"issue":"1","key":"2641_CR133","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12967-021-03196-4","volume":"19","author":"W Lv","year":"2021","unstructured":"Lv W, Tan Y, Xiong M, Zhao C, Wang Y, Wu M, et al. Analysis and validation of m6A regulatory network: a novel circBACH2\/has-miR-944\/HNRNPC axis in breast cancer progression. J Transl Med. 2021;19(1):527.","journal-title":"J Transl Med"},{"issue":"1","key":"2641_CR134","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12(1):295.","journal-title":"Nat Commun"},{"issue":"1","key":"2641_CR135","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-021-01359-x","volume":"20","author":"F Xie","year":"2021","unstructured":"Xie F, Huang C, Liu F, Zhang H, Xiao X, Sun J, et al. CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression. Mol Cancer. 2021;20(1):68.","journal-title":"Mol Cancer"},{"key":"2641_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216189","volume":"562","author":"J Zhou","year":"2023","unstructured":"Zhou J, Xie H, Liu J, Huang R, Xiang Y, Tian D, et al. PIWI-interacting RNAs: critical roles and therapeutic targets in cancer. Cancer Lett. 2023;562: 216189.","journal-title":"Cancer Lett"},{"issue":"4","key":"2641_CR137","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.7150\/thno.21740","volume":"8","author":"X Liu","year":"2018","unstructured":"Liu X, Zheng J, Xue Y, Yu H, Gong W, Wang P, et al. PIWIL3\/OIP5-AS1\/miR-367-3p\/CEBPA feedback loop regulates the biological behavior of glioma cells. Theranostics. 2018;8(4):1084\u2013105.","journal-title":"Theranostics"},{"issue":"1","key":"2641_CR138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhu Y, Cao X, Tan W, Yu J, Lu Y, et al. The epigenetic regulatory mechanism of PIWI\/piRNAs in human cancers. Mol Cancer. 2023;22(1):45.","journal-title":"Mol Cancer"},{"issue":"6","key":"2641_CR139","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.21037\/tcr-23-790","volume":"12","author":"S Huang","year":"2023","unstructured":"Huang S, Chen B, Qiu P, Yan Z, Liang Z, Luo K, et al. In vitro study of piwi interaction RNA-31106 promoting breast carcinogenesis by regulating METTL3-mediated m6A RNA methylation. Transl Cancer Res. 2023;12(6):1588\u2013601.","journal-title":"Transl Cancer Res"},{"key":"2641_CR140","doi-asserted-by":"crossref","unstructured":"Du SM, Li N, Xu WJ, Liu K. Triple\u2011negative breast cancer cell\u2011derived piR\u201131115 promotes the proliferation and migration of endothelial cells via METTL3\u2011mediated m6A modification of YAP1. Oncol Rep. 2025;53(3):34.","DOI":"10.3892\/or.2025.8867"},{"issue":"9","key":"2641_CR141","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.7150\/jca.83446","volume":"14","author":"L Liu","year":"2023","unstructured":"Liu L, Li L, Zu W, Jing J, Liu G, Sun T, et al. PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. J Cancer. 2023;14(9):1648\u201359.","journal-title":"J Cancer"},{"issue":"1","key":"2641_CR142","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12967-022-03257-2","volume":"20","author":"Q Xie","year":"2022","unstructured":"Xie Q, Li Z, Luo X, Wang D, Zhou Y, Zhao J, et al. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner. J Transl Med. 2022;20(1):51.","journal-title":"J Transl Med"},{"issue":"1","key":"2641_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-025-07340-6","volume":"16","author":"J Yuan","year":"2025","unstructured":"Yuan J, Xie BM, Ji YM, Bao HJ, Wang JL, Cheng JC, et al. piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1. Cell Death Dis. 2025;16(1):25.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2641_CR144","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41419-022-05317-3","volume":"13","author":"B Ou","year":"2022","unstructured":"Ou B, Liu Y, Gao Z, Xu J, Yan Y, Li Y, et al. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation. Cell Death Dis. 2022;13(10):905.","journal-title":"Cell Death Dis"},{"key":"2641_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123527","volume":"368","author":"S Chen","year":"2025","unstructured":"Chen S, Wen JT, Zhang S, Wang JL, Yuan J, Bao HJ, et al. SNORD9 promotes ovarian cancer tumorigenesis via METTL3\/IGF2BP2-mediated NFYA m6A modification and is a potential target for antisense oligonucleotide therapy. Life Sci. 2025;368: 123527.","journal-title":"Life Sci"},{"issue":"1","key":"2641_CR146","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13075-024-03290-0","volume":"26","author":"G Li","year":"2024","unstructured":"Li G, Fang Y, Xu N, Ding Y, Liu D. Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes. Arthritis Res Ther. 2024;26(1):56.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2641_CR147","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.apsb.2016.09.002","volume":"7","author":"X An","year":"2017","unstructured":"An X, Sarmiento C, Tan T, Zhu H. Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sin B. 2017;7(1):38\u201351.","journal-title":"Acta Pharm Sin B"},{"key":"2641_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100851","volume":"63","author":"D Singh","year":"2022","unstructured":"Singh D, Assaraf YG, Gacche RN. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resist Updat. 2022;63: 100851.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2641_CR149","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-020-01240-3","volume":"19","author":"T Xu","year":"2020","unstructured":"Xu T, Wang M, Jiang L, Ma L, Wan L, Chen Q, et al. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer. 2020;19(1):127.","journal-title":"Mol Cancer"},{"issue":"6","key":"2641_CR150","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.18632\/aging.102950","volume":"12","author":"P Liu","year":"2020","unstructured":"Liu P, Zhang B, Chen Z, He Y, Du Y, Liu Y, et al. m(6)A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145\/FAK pathway. Aging. 2020;12(6):5280\u201399.","journal-title":"Aging"},{"issue":"1","key":"2641_CR151","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00432-023-05572-7","volume":"150","author":"A Shi","year":"2024","unstructured":"Shi A, Liu L, Li S, Qi B. Natural products targeting the MAPK-signaling pathway in cancer: overview. J Cancer Res Clin Oncol. 2024;150(1):6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2641_CR152","doi-asserted-by":"crossref","unstructured":"Lee S, Rauch J, Kolch W. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21(3):1102.","DOI":"10.3390\/ijms21031102"},{"issue":"18","key":"2641_CR153","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1056\/NEJMoa2404139","volume":"391","author":"GV Long","year":"2024","unstructured":"Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, et al. Final results for adjuvant dabrafenib plus trametinib in stage III melanoma. N Engl J Med. 2024;391(18):1709\u201320.","journal-title":"N Engl J Med"},{"key":"2641_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107206","volume":"204","author":"XY Chen","year":"2024","unstructured":"Chen XY, Yang YL, Yu Y, Chen ZY, Fan HN, Zhang J, et al. CircUGGT2 downregulation by METTL14-dependent m(6)A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p\/MAP3K9 axis. Pharmacol Res. 2024;204: 107206.","journal-title":"Pharmacol Res"},{"key":"2641_CR155","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.canlet.2021.08.007","volume":"520","author":"T Wang","year":"2021","unstructured":"Wang T, Liu Z, She Y, Deng J, Zhong Y, Zhao M, et al. A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis. Cancer Lett. 2021;520:321\u201331.","journal-title":"Cancer Lett"},{"key":"2641_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.783385","volume":"9","author":"Z Liu","year":"2021","unstructured":"Liu Z, Lu J, Fang H, Sheng J, Cui M, Yang Y, et al. m6A modification-mediated DUXAP8 regulation of malignant phenotype and chemotherapy resistance of hepatocellular carcinoma through miR-584-5p\/MAPK1\/ERK pathway axis. Front Cell Dev Biol. 2021;9: 783385.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2641_CR157","doi-asserted-by":"publisher","first-page":"2298058","DOI":"10.1080\/15592294.2023.2298058","volume":"19","author":"J Lai","year":"2024","unstructured":"Lai J, Zhou Z, Hu K, Yu H, Su X, Niu X, et al. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. Epigenetics. 2024;19(1):2298058.","journal-title":"Epigenetics"},{"issue":"1","key":"2641_CR158","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"1","key":"2641_CR159","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12967-023-04651-0","volume":"21","author":"J Liu","year":"2023","unstructured":"Liu J, Gu X, Guan Z, Huang D, Xing H, Zheng L. Role of m6A modification in regulating the PI3K\/AKT signaling pathway in cancer. J Transl Med. 2023;21(1):774.","journal-title":"J Transl Med"},{"issue":"12","key":"2641_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24761","volume":"36","author":"S Cui","year":"2022","unstructured":"Cui S. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K\/AKT pathway. J Clin Lab Anal. 2022;36(12): e24761.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2641_CR161","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-023-01917-5","volume":"23","author":"H Li","year":"2024","unstructured":"Li H, Lin R, Zhang Y, Zhu Y, Huang S, Lan J, et al. N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation. Mol Cancer. 2024;23(1):5.","journal-title":"Mol Cancer"},{"issue":"10","key":"2641_CR162","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41419-020-03049-w","volume":"11","author":"Y Sun","year":"2020","unstructured":"Sun Y, Li S, Yu W, Zhao Z, Gao J, Chen C, et al. N(6)-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN\/TMEM127 and promotes sensitivity to everolimus in gastric cancer. Cell Death Dis. 2020;11(10):836.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR163","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41420-022-01234-8","volume":"8","author":"H Wang","year":"2022","unstructured":"Wang H, Wang Y, Lai S, Zhao L, Liu W, Liu S, et al. LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2. Cell Death Discov. 2022;8(1):449.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2641_CR164","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-022-01647-0","volume":"21","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu X, Wang Y, Lai S, Wang Z, Yang Y, et al. The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol Cancer. 2022;21(1):174.","journal-title":"Mol Cancer"},{"issue":"9","key":"2641_CR165","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1111\/jcmm.16478","volume":"25","author":"X Lai","year":"2021","unstructured":"Lai X, Wei J, Gu XZ, Yao XM, Zhang DS, Li F, et al. Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells. J Cell Mol Med. 2021;25(9):4248\u201359.","journal-title":"J Cell Mol Med"},{"key":"2641_CR166","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pharmthera.2018.11.008","volume":"196","author":"P Huang","year":"2019","unstructured":"Huang P, Yan R, Zhang X, Wang L, Ke X, Qu Y. Activating Wnt\/beta-catenin signaling pathway for disease therapy: challenges and opportunities. Pharmacol Ther. 2019;196:79\u201390.","journal-title":"Pharmacol Ther"},{"key":"2641_CR167","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781\u2013810.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2641_CR168","doi-asserted-by":"crossref","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46.","DOI":"10.1186\/s13045-024-01563-4"},{"key":"2641_CR169","doi-asserted-by":"crossref","unstructured":"Reyes M, Flores T, Betancur D, Pena-Oyarzun D, Torres VA. Wnt\/beta-catenin signaling in oral carcinogenesis. Int J Mol Sci. 2020;21(13):4682.","DOI":"10.3390\/ijms21134682"},{"issue":"6","key":"2641_CR170","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399.","journal-title":"Cell"},{"issue":"17","key":"2641_CR171","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-22-0791","volume":"28","author":"S Guan","year":"2022","unstructured":"Guan S, Chen X, Chen Y, Xie W, Liang H, Zhu X, et al. FOXM1 variant contributes to gefitinib resistance via activating Wnt\/\u03b2-catenin signal pathway in patients with non-small cell lung cancer. Clin Cancer Res. 2022;28(17):3770\u201384.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2641_CR172","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41419-023-05933-7","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin J, Ding F, Cheng Z, Ge X, Li Y, Zeng A, et al. METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt\/beta-catenin signaling. Cell Death Dis. 2023;14(7):417.","journal-title":"Cell Death Dis"},{"issue":"7","key":"2641_CR173","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/10985549.2023.2210032","volume":"43","author":"J Li","year":"2023","unstructured":"Li J, Ma J, Huang S, Li J, Zhou L, Sun J, et al. CircTTLL13 promotes TMZ resistance in glioma via modulating OLR1-mediated activation of the Wnt\/beta-Catenin pathway. Mol Cell Biol. 2023;43(7):354\u201369.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2641_CR174","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-023-01811-0","volume":"22","author":"K Li","year":"2023","unstructured":"Li K, Peng ZY, Wang R, Li X, Du N, Liu DP, et al. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Mol Cancer. 2023;22(1):103.","journal-title":"Mol Cancer"},{"issue":"1","key":"2641_CR175","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","volume":"19","author":"J Xu","year":"2020","unstructured":"Xu J, Wan Z, Tang M, Lin Z, Jiang S, Ji L, et al. N(6)-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating beta-catenin signaling. Mol Cancer. 2020;19(1):163.","journal-title":"Mol Cancer"},{"issue":"11","key":"2641_CR176","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41419-023-06244-7","volume":"14","author":"J Lu","year":"2023","unstructured":"Lu J, Yang Y, Liu X, Chen X, Song W, Liu Z. FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p\/WNT5A\/WNT pathway in PDAC. Cell Death Dis. 2023;14(11):713.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR177","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13062-022-00347-5","volume":"17","author":"C Lin","year":"2022","unstructured":"Lin C, Wang Y, Dong Y, Lai S, Wang L, Weng S, et al. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway. Biol Direct. 2022;17(1):33.","journal-title":"Biol Direct"},{"issue":"4","key":"2641_CR178","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cac2.12534","volume":"44","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang J, Liu H, Meng L, Gao X, Zhao Y, et al. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. Cancer Commun (Lond). 2024;44(4):469\u201390.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"2641_CR179","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-022-01555-3","volume":"21","author":"H Liu","year":"2022","unstructured":"Liu H, Li D, Sun L, Qin H, Fan A, Meng L, et al. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m(6)A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression. Mol Cancer. 2022;21(1):74.","journal-title":"Mol Cancer"},{"issue":"1","key":"2641_CR180","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7(1):376.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"2641_CR181","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-022-05050-x","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang SQ, Wang L, Lin H, Zhu JB, Chen R, et al. m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression. Cell Death Dis. 2022;13(7):657.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR182","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2641_CR183","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2641_CR184","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12885-022-09848-y","volume":"22","author":"Q Ling","year":"2022","unstructured":"Ling Q, Wu S, Liao X, Liu C, Chen Y. Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p\/RAP1-NF-kappaB axis. BMC Cancer. 2022;22(1):765.","journal-title":"BMC Cancer"},{"issue":"1","key":"2641_CR185","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther. 2022;7(1):95.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2641_CR186","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, et al. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther. 2024;9(1):128.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2641_CR187","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13046-021-02137-9","volume":"40","author":"K Li","year":"2021","unstructured":"Li K, Peng ZY, Gao S, Wang QS, Wang R, Li X, et al. M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way. J Exp Clin Cancer Res. 2021;40(1):325.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2641_CR188","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-023-05840-x","volume":"14","author":"J Dai","year":"2023","unstructured":"Dai J, Qu T, Yin D, Cui Y, Zhang C, Zhang E, et al. LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer. Cell Death Dis. 2023;14(5):312.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR189","doi-asserted-by":"publisher","first-page":"20730","DOI":"10.1038\/s41598-023-47956-2","volume":"13","author":"J Wang","year":"2023","unstructured":"Wang J, Xu J, Zheng J. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner. Sci Rep. 2023;13(1):20730.","journal-title":"Sci Rep"},{"issue":"1","key":"2641_CR190","doi-asserted-by":"publisher","first-page":"2217033","DOI":"10.1080\/15592294.2023.2217033","volume":"18","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Cao Y, Yang Y, Wang S, Chen F. METTL3-mediated m(6)A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p\/MDR1 axis. Epigenetics. 2023;18(1):2217033.","journal-title":"Epigenetics"},{"issue":"4","key":"2641_CR191","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-021-03558-2","volume":"12","author":"P Wu","year":"2021","unstructured":"Wu P, Fang X, Liu Y, Tang Y, Wang W, Li X, et al. N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway. Cell Death Dis. 2021;12(4):298.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2641_CR192","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","volume":"23","author":"F Luo","year":"2024","unstructured":"Luo F, Zhang M, Sun B, Xu C, Yang Y, Zhang Y, et al. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1alpha signaling. Mol Cancer. 2024;23(1):60.","journal-title":"Mol Cancer"},{"issue":"1","key":"2641_CR193","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13018-023-04502-0","volume":"19","author":"D Zhang","year":"2024","unstructured":"Zhang D, Guo Q, You K, Zhang Y, Zheng Y, Wei T. m(6)A-modified circARHGAP12 promotes the aerobic glycolysis of doxorubicin-resistance osteosarcoma by targeting c-Myc. J Orthop Surg Res. 2024;19(1):33.","journal-title":"J Orthop Surg Res"},{"key":"2641_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zheng N, Li J, Li C, Zheng D, Jiang X, et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat. 2022;65: 100886.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2641_CR195","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang Z, He J, Bach DH, Huang YH, Li Z, Liu H, et al. Induction of m(6)A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance. J Exp Clin Cancer Res. 2022;41(1):4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"2641_CR196","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/1878-0261.13323","volume":"17","author":"HS Yang","year":"2023","unstructured":"Yang HS, Cai HY, Shan SC, Chen TF, Zou JY, Abudurufu M, et al. Methylation of N6 adenosine-related long noncoding RNA: effects on prognosis and treatment in \u201cdriver-gene-negative\u201d lung adenocarcinoma. Mol Oncol. 2023;17(2):365\u201377.","journal-title":"Mol Oncol"},{"issue":"7860","key":"2641_CR197","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593(7860):597\u2013601.","journal-title":"Nature"},{"key":"2641_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117366","volume":"179","author":"X Chen","year":"2024","unstructured":"Chen X, Wang M, Wang H, Yang J, Li X, Zhang R, et al. METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3\/AKT pathway and synergizes with PARP inhibitor. Biomed Pharmacother. 2024;179: 117366.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2641_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114165","volume":"43","author":"M Pomaville","year":"2024","unstructured":"Pomaville M, Chennakesavalu M, Wang P, Jiang Z, Sun HL, Ren P, et al. Small-molecule inhibition of the METTL3\/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation. Cell Rep. 2024;43(5): 114165.","journal-title":"Cell Rep"},{"issue":"12","key":"2641_CR200","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1021\/acsptsci.4c00533","volume":"7","author":"M Tarullo","year":"2024","unstructured":"Tarullo M, Fernandez Rodriguez G, Iaiza A, Venezia S, Macone A, Incocciati A, et al. Off-target inhibition of human dihydroorotate dehydrogenase (hDHODH) highlights challenges in the development of fat mass and obesity-associated protein (FTO) inhibitors. ACS Pharmacol Transl Sci. 2024;7(12):4096\u2013111.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"2641_CR201","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.apsb.2024.09.009","volume":"15","author":"MS Attia","year":"2025","unstructured":"Attia MS, Kijanka G, Nguyen NT, Zhang J, An H. Advances and prospects of RNA delivery nanoplatforms for cancer therapy. Acta Pharmaceut Sin B. 2025;15(1):52\u201396.","journal-title":"Acta Pharmaceut Sin B"},{"key":"2641_CR202","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bioactmat.2023.11.007","volume":"33","author":"RR Singh","year":"2024","unstructured":"Singh RR, Mondal I, Janjua T, Popat A, Kulshreshtha R. Engineered smart materials for RNA based molecular therapy to treat Glioblastoma. Bioactive Mater. 2024;33:396\u2013423.","journal-title":"Bioactive Mater"},{"issue":"6","key":"2641_CR203","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1021\/acs.accounts.9b00101","volume":"52","author":"RA Revia","year":"2019","unstructured":"Revia RA, Stephen ZR, Zhang M. Theranostic nanoparticles for RNA-based cancer treatment. Acc Chem Res. 2019;52(6):1496\u2013506.","journal-title":"Acc Chem Res"},{"issue":"12","key":"2641_CR204","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/s41587-020-0572-6","volume":"38","author":"C Wilson","year":"2020","unstructured":"Wilson C, Chen PJ, Miao Z, Liu DR. Programmable m(6)A modification of cellular RNAs with a Cas13-directed methyltransferase. Nat Biotechnol. 2020;38(12):1431\u201340.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"2641_CR205","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","volume":"21","author":"JL Childs-Disney","year":"2022","unstructured":"Childs-Disney JL, Yang X, Gibaut QMR, Tong Y, Batey RT, Disney MD. Targeting RNA structures with small molecules. Nat Rev Drug Discov. 2022;21(10):736\u201362.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02641-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02641-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02641-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T11:02:07Z","timestamp":1748170927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02641-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":205,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2641"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02641-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"920"}}